1. International Agency for Research on Cancer (2003) Fruit and Vegetables. IARC Handbooks of Cancer Prevention, vol. 8. Lyon, France: IARC Press.
2. Anand P, Kunnumakara AB, Sundaram C et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25, 2097–2116.
3. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research.
4. World Cancer Research Fund and American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research.
5. World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series no. 916. Geneva: WHO.
6. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3, 364–373.
7. Stan SD, Kar S, Stoner GD et al. (2007) Bioactive food components and cancer risk reduction. J Cell Biochem 104, 339–356.
8. Aggarwal BB & Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397–1421.
9. Lampe JW (1999) Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr 70, 475S–490S.
10. Oganesian A, Hendricks JD & Williams DE (1997) Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett 118, 87–94.
11. Srivastava B & Shukla Y (1998) Antitumour promoting activity of indole-3-carbinol in mouse skin carcinogenesis. Cancer Lett 134, 91–95.
12. Zhang J, Hsu BAJ, Kinseth BAM et al. (2003) Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 98, 2511–2520.
13. Frydoonfar HR, McGrath DR & Spigelman AD (2002) Inhibition of proliferation of a colon cancer cell line by indole-3-carbinol. Colorectal Dis 4, 205–207.
14. Grose KR & Bjeldanes LF (1992) Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5, 188–193.
15. De Kruif CA, Marsman JW, Venekamp JC et al. (1991) Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact 80, 303–315.
16. Stresser DM, Williams DE, Griffin DA et al. (1995) Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab Dispos 23, 965–975.
17. Chang X, Tou JC, Hong C et al. (2005) 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26, 771–778.
18. Nachshon-Kedmi M, Fares FA & Yannai S (2004) Therapeutic activity of 3,3′-diindolylmethane on prostate cancer in an in vivo model. Prostate 61, 153–160.
19. Safe S (2001) Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120, 1–7.
20. Wolf CR (2001) Chemoprevention: increased potential to bear fruit. Proc Natl Acad Sci U S A 98, 2941–2943.
21. Talalay P & Fahey JW (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131, 3027S–3033.
22. Cho HJ, Seon MR, Lee YM et al. (2008) 3,3′-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr 138, 17–23.
23. Abdelrahim M, Newman K, Vanderlaag K et al. (2006) 3,3′-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 27, 717–728.
24. Kim EJ, Park SY, Shin HK et al. (2007) Activation of caspase-8 contributes to 3,3′-diindolylmethane-induced apoptosis in colon cancer cells. J Nutr 137, 31–36.
25. Hong C, Kim HA, Firestone GL et al. (2002) 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23, 1297–1305.
26. Firestone GL & Bjeldanes LF (2003) Indole-3-carbinol and 3-3′-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 133, 2448S–2455S.
27. Bonnesen C, Eggleston IM & Hayes JD (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61, 6120–6130.
28. Kong AN, Owuor E, Yu R et al. (2001) Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 33, 255–271.
29. Kolm RH, Danielson UH, Zhang Y et al. (1995) Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem J 311, 453–459.
30. Shapiro TA, Fahey JW, Wade KL et al. (1998) Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarkers Prev 7, 1091–1100.
31. Zhang Y, Yao S & Li J (2006) Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action. Proc Nutr Soc 65, 68–75.
32. Higdon JV, Delage B, Williams DE et al. (2007) Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55, 224–236.
33. International Agency for Research on Cancer (2004) Cruciferous vegetables, isothiocyanates and Indoles. IARC Handbooks of Cancer Prevention, vol. 9. Lyon, France: IARC.
34. Smith-Warner SA, Spiegelman D, Yaun S-S et al. (2001) Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 285, 769–776.
35. Smith-Warner SA, Spiegelman D, Yaun S-S et al. (2003) Fruits, vegetables and lung cancer: A pooled analysis of cohort studies. Int J Cancer 107, 1001–1011.
36. Koushik A, Hunter DJ, Spiegelman D et al. (2005) Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 14, 2160–2167.
37. Koushik A, Hunter DJ, Spiegelman D et al. (2007) Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 99, 1471–1483.
38. Lee JE, Giovannucci E, Smith-Warner SA et al. (2006) Intakes of fruits, vegetables, vitamins a, c, and e, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 15, 2445–2452.
39. Steinmetz KA & Potter JD (1996) Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 96, 1027–1039.
40. Hara M, Hanaoka T, Kobayashi M et al. (2003) Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 46, 138–147.
41. Chyou P-H, Nomura AMY, Hankin JH et al. (1990) A case-cohort study of diet and stomach cancer. Cancer Res 50, 7501–7504.
42. Smith-Warner SA, Genkinger J & Giovannucci E (2006) Fruit and vegetable intake and cancer. In Nutritional Oncology, 2nd ed., pp. 97–173 [Heber D, Blackburn GL, Go VL and Milner J editors]. Burlington, MA: Elsevier.
43. Voorrips LE, Goldbohm RA, Verhoeven DTH et al. (2000) Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on Diet and Cancer. Cancer Causes Control 11, 101–115.
44. Neuhouser ML, Patterson RE, Thornquist MD et al. (2003) Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev 12, 350–358.
45. Feskanich D, Ziegler RG, Michaud DS et al. (2000) Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 92, 1812–1823.
46. Miller AB, Altenburg HP, Bueno-de-Mesquita B et al. (2004) Fruits and vegetables and lung cancer: Findings from the European prospective investigation into cancer and nutrition. Int J Cancer 108, 269–276.
47. Verhoeven DT, Goldbohm RA, van Poppel G et al. (1996) Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5, 733–748.
48. Kristal AR & Lampe JW (2002) Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer 42, 1–9.
49. Kolonel LN, Hankin JH, Whittemore AS et al. (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9, 795–804.
50. Cohen JH, Kristal AR & Stanford JL (2000) Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 92, 61–68.
51. Joseph MA, Moysich KB, Freudenheim JL et al. (2004) Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 50, 206–213.
52. Jain MG, Hislop GT, Howe GR et al. (1999) Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer 34, 173–184.
53. Giovannucci E, Rimm E, Liu Y et al. (2003) A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev 12, 1403–1409.
54. Kirsh VA, Peters U, Mayne ST et al. (2007) Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 99, 1200–1209.
55. Key TJ, Allen N, Appleby P et al. (2004) Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 109, 119–124.
56. Ambrosone CB, McCann SE, Freudenheim JL et al. (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 134, 1134–1138.
57. Terry P, Wolk A, Persson I et al. (2001) Brassica vegetables and breast cancer risk. JAMA 285, 2975–2977.
58. Michaud DS, Spiegelman D, Clinton SK et al. (1999) Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91, 605–613.
59. Michaud DS, Pietinen P, Taylor PR et al. (2002) Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer 87, 960–965.
60. Zhao H, Lin J, Grossman HB et al. (2007) Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 120, 2208–2213.
61. Bandera EV, Kushi LH, Moore DF et al. (2007) Fruits and vegetables and endometrial cancer risk: a systematic literature review and meta-analysis. Nutr Cancer 58, 6–21.
62. Littman AJ, Beresford SA & White E (2001) The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 12, 691–702.
63. Tao MH, Xu WH, Zheng W et al. (2005) A case-control study in Shanghai of fruit and vegetable intake and endometrial cancer. Br J Cancer 92, 2059–2064.
64. Goodman MT, Hankin JH, Wilkens LR et al. (1997) Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 57, 5077–5085.
65. Lampe JW & Peterson S (2002) Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 132, 2991–2994.
66. Seow A, Vainio H & Yu MC (2005) Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat Res 592, 58–67.
67. Ahn J, Gammon MD, Santella RM et al. (2006) Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27, 1876–1882.
68. Ye Z, Song H, Higgins JPT et al. (2006) Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3, 524–534.
69. Seow A, Yuan JM, Sun CL et al. (2002) Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23, 2055–2061.
70. Wang LI, Giovannucci EL, Hunter D et al. (2004) Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes and Control 15, 977–985.
71. London SJ, Yuan JM, Chung FL et al. (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356, 724–729.
72. Steck SE, Gaudet MM, Britton JA et al. (2007) Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 28, 1954–1959.
73. Gaudet MM, Olshan AF, Poole C et al. (2004) Diet, GSTM1 and GSTT1 and head and neck cancer. Carcinogenesis 25, 735–740.
74. Moore LE, Brennan P, Karami S et al. (2007) Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis 28, 1960–1964.
75. Tijhuis MJ, Wark PA, Aarts JMMJG et al. (2005) GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 14, 2943–2951.
76. Lin HJ, Probst-Hensch NM, Louie AD et al. (1998) Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7, 647–652.
77. Zhao B, Seow A, Lee EJ et al. (2001) Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 10, 1063–1067.
78. Gammon MD, Neugut AI, Santella RM et al. (2002) The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74, 235–254.